Sector | Healthcare | Compare with Sector peers |
Industry | Hospital & Healthcare Services | Compare with Industry peers |
Website | http://www.asterdmhealthcare.com | |
Market Cap | 26,077.08 Cr. | |
Enterprise Value(EV) | 27,987.56 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 6.49 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | 80.46 | Trailing Twelve Months Ending 2023-12 |
Industry PE | 66.40 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 91.90 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 5.68 | Calculated using Price: 522.05 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 49.95 Cr. | 499,513,060 Shares |
FaceValue | 10 | |
About Aster DM Healthcare Ltd. | ||
The company operates in multiple segments of the healthcare industry, including hospitals, clinics and retail pharmacies and provide healthcare services to patients across economic segments in several GCC states through its various brands “Aster”, “Medcare” and “Access”. A majority of its hospitals and clinics provide secondary and tertiary healthcare services to patients. In addition to providing core medical, surgical and emergency services, some of its hospitals provide complex and advanced quaternary healthcare in various specialties, including cardiology, oncology, radiology, ophthalmology, neurosciences, paediatrics, gastroenterology, orthopaedics and critical care services. |
1 Day |
|
+0.41% |
1 Week |
|
+10.11% |
1 Month |
|
+20.98% |
3 Month |
|
+22.68% |
6 Month |
|
+55.28% |
1 Year |
|
+109.28% |
2 Year |
|
+174.84% |
5 Year |
|
+243.45% |
10 Year |
|
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 18.33 | 0.86 | 8.5 | 11.97 | 12.15 | 9.7 | 5.35 | 16.41 | 11.32 | |
Return on Capital Employed (%) | 15.42 | 7.69 | 11.45 | 10.43 | 11 | 11.77 | 9.03 | 15.96 | 14.36 | |
Return on Assets (%) | 6.17 | 0.16 | 1.55 | 3.94 | 4.48 | 2.95 | 1.48 | 4.98 | 3.48 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 1,484 | 420 | 1,875 | 2,832 | 3,214 | 3,272 | 3,372 | 3,953 | 4,448 | 4,373 | |
Non Curr. Liab. | 924 | 3,180 | 2,352 | 2,066 | 2,581 | 4,965 | 4,590 | 4,480 | 5,320 | 5,470 | |
Curr. Liab. | 1,239 | 1,967 | 2,201 | 2,224 | 2,668 | 3,722 | 3,196 | 3,559 | 4,655 | 5,372 | |
Minority Int. | 762 | 177 | 375 | 358 | 466 | 446 | 462 | 529 | 412 | 436 | |
Equity & Liab. | 4,409 | 5,743 | 6,804 | 7,479 | 8,928 | 12,405 | 11,620 | 12,521 | 14,836 | 15,651 | |
Non Curr. Assets | 2,609 | 3,237 | 4,332 | 4,610 | 5,311 | 8,310 | 7,991 | 8,425 | 9,914 | 10,455 | |
Curr. Assets | 1,801 | 2,506 | 2,472 | 2,869 | 3,617 | 4,096 | 3,629 | 4,096 | 4,922 | 5,195 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 4,409 | 5,743 | 6,804 | 7,479 | 8,928 | 12,405 | 11,620 | 12,521 | 14,836 | 15,651 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 3,876 | 5,250 | 5,931 | 6,721 | 7,963 | 8,652 | 8,608 | 10,253 | 11,933 | 13,505 | |
Other Income | 23 | 25 | 37 | 45 | 35 | 38 | 50 | 51 | 78 | 40 | |
Total Income | 3,899 | 5,275 | 5,968 | 6,767 | 7,997 | 8,690 | 8,658 | 10,304 | 12,011 | 13,545 | |
Total Expenditure | -3,358 | -4,789 | -5,582 | -6,089 | -7,074 | -7,363 | -7,506 | -8,720 | -10,307 | -11,670 | |
PBIDT | 541 | 486 | 386 | 678 | 924 | 1,327 | 1,153 | 1,584 | 1,704 | 1,874 | |
Interest | -91 | -205 | -371 | -204 | -205 | -391 | -334 | -307 | -390 | -395 | |
Depreciation | -144 | -243 | -322 | -298 | -306 | -586 | -618 | -641 | -780 | -895 | |
Taxation | -34 | -29 | -11 | -26 | -43 | -15 | -27 | -36 | -60 | -111 | |
Exceptional Items | 416 | 130 | -2 | -20 | -55 | ||||||
PAT | 272 | 8 | 98 | 282 | 367 | 315 | 178 | 601 | 475 | 419 | |
Minority Interest | -139 | -67 | 4 | -13 | -34 | -38 | -30 | -75 | -51 | -72 | |
Share Associate | -22 | ||||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | 133 | -59 | 102 | 269 | 333 | 277 | 148 | 526 | 425 | 324 | |
Adjusted EPS | 3 | -1 | 3 | 5 | 7 | 6 | 3 | 11 | 9 | 6 |
Particulars | 9 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 236 | 203 | 361 | 537 | 601 | 1,223 | 1,569 | 1,314 | 1,834 | |
Cash Fr. Inv. | -448 | -786 | -1,153 | -523 | -709 | -667 | -330 | -570 | -972 | |
Cash Fr. Finan. | 203 | 578 | 654 | 46 | 134 | -675 | -1,116 | -686 | -817 | |
Net Change | -10 | -5 | -138 | 61 | 26 | -119 | 123 | 58 | 45 | |
Cash & Cash Eqvt | 248 | 253 | 131 | 192 | 225 | 115 | 235 | 299 | 365 |
Wed, 17 Apr 2024
Announcement under Regulation 30 (LODR)-Acquisition Pursuant to Regulation 30 of the SEBI (LODR) Regulations 2015 we hereby inform that Aster DM Healthcare Limited and Malabar Institute of Medical Sciences Limited (MIMS) a material subsidiary of Aster DM Healthcare Limited has signed a definitive agreement on April 17 2024 to acquire 26% stake in Oyster Green Hybrid Two Private Limited. We request you to kindly take the same on record. |
Tue, 16 Apr 2024
Announcement under Regulation 30 (LODR)-Credit Rating Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 Please be informed that ICRA Limited has upgraded the credit ratings of the Company for total credit facility of Rs. 602 crores. Request you to kindly take the same on record. |
Mon, 15 Apr 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Deutsche Bank AG |
Thu, 18 Apr 2024 |
Close Within 52 Week High Zone |
High Increase in 1 Month |
High Increase in 3 Months |
High Increase in 6 Months |
High Increase in 1 Year |